parsaclisib,ibrutinib,rituximab,bendamustine
incyte,janssen,abbvie,roche
['ibru', 'lymsm', 'lymphoma', 'parsaclisib']
#eha2022 a phase 1 study of #parsaclisib in combination with br or ibrutinib in pts with previously treated b-cell #lymphoma #lymsm 
Lymphoma Unit @Hospital_FJD & @UICOquironsalud. Board member @sehh_es & @SIOGorg. Councilor @EHA_Hematology Executive Board. Chairman SWG “Aging and Hematology”